| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 22 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 426.3K | $15.23M | - | |
| CFO | 403.3K | $14.41M | - | |
| Dir | 367.6K | $13.13M | - | |
| VP | 148.8K | $5.32M | - | |
| Dir | 115.7K | $4.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Francis Richard D | President And CEO | Sale+OE | 23,773 | $15.80 | $375,533.70 | -4.1% | +8.1% | +99.7% | |
| Mar 4, 2025 | Hughes Eric A | See "remarks" | Sale+OE | 24,900 | $16.06 | $399,770.20 | -82.8% | +10.0% | +109.8% | |
| Mar 4, 2025 | Francis Richard D | President And CEO | Sale+OE | 31,342 | $16.06 | $503,235.99 | -5.9% | +10.0% | +109.8% | |
| Mar 4, 2025 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 62,250 | $16.06 | $999,424.86 | -82.8% | +10.0% | +109.8% | |
| Feb 28, 2025 | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | Sale+OE | 55,750 | $16.21 | $903,462.20 | -27.4% | +6.5% | +105.7% | |
| Feb 18, 2025 | Francis Richard D | President And CEO | Sale+OE | 75,506 | $16.95 | $1,279,660.59 | -26.5% | +2.7% | +105.9% | |
| Feb 12, 2025 | Sabag Mark | See "remarks" | Sell | 177,626 | $16.25 | $2,886,564.60 | -46.4% | +7.0% | +107.6% | |
| Dec 20, 2024 | Mignone Roberto | Director | Sell | 286,000 | $22.01 | $6,294,030.60 | -29.2% | -26.5% | +37.4% | |
| Nov 20, 2024 | Fox Christine | EVP, Head Of U.s. Commercial | Sale+OE | 19,388 | $16.87 | $327,085.25 | -30.5% | -2.7% | +42.6% | |
| Aug 12, 2024 | Daniell Richard | Exec. VP, European Commercial | Sell | 98,943 | $17.30 | $1,711,446.75 | -100% | +1.7% | -2.8% |